Clinical Trials Browser

Interventional × Hodgkin Disease × ibrutinib × Clear all

NCT02824029 2025-02-17

Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Phase 2 Completed

28 enrolled 11 charts

Hodgkin Disease

NCT02869633 2023-10-23

Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant

Phase 2 Completed

23 enrolled 10 charts

LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT02626884 2021-04-08

IRENO

Phase 2 Completed

Hodgkin Disease